logo

Cerecor Inc. (CERC)



Trade CERC now with
  Date
  Headline
11/6/2017 8:17:12 AM Cerecor Q3 Net Income $18.7 Mln Or $0.52/shr Vs Net Loss Of $6.2 Mln Or $0.70/shr Prior Year
10/18/2017 8:16:21 AM Cerecor Regains Compliance With NASDAQ Minimum Bid Price Requirement
8/14/2017 8:40:15 AM Cerecor Announces Divestiture Of CERC-501 To Janssen Pharma
8/14/2017 8:18:23 AM Cerecor Q2 Net Loss $1.8 Mln Or $0.14 Per Share Vs Net Loss $3.5 Mln Or $0.41 Per Share Last Year
8/14/2017 8:11:50 AM Cerecor Announces Retirement Of Uli Hacksell As President And CEO, Effective August 14
5/15/2017 8:41:44 AM Cerecor Adds Steven Boyd And Peter Greenleaf To Its Board
5/9/2017 8:38:42 AM Cerecor Q1 Net Loss $2.0 Mln Or $0.19 Per Share Vs Net Loss $5.1 Mln Or $0.59/Sr Last Year
12/5/2016 8:11:38 AM Cerecor Announces Results From CERC-501 Phase 2 Study For Nicotine Withdrawal
11/8/2016 9:22:39 AM Cerecor Q3 Loss Per Share $0.70 Vs Loss $1.06 Last Year
9/21/2016 9:12:17 AM Cerecor Closes Enrollment In Phase 2 Trial With CERC-301 As Oral, Adjunctive Treatment Of Major Depressive Disorder